Ligand PharmaceuticalsLGND 
$120.43-1.56%24h
-1.56%24h
Global rank1666
Market cap$2.10B
Change 7d-0.62%
YTD Performance68.46%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Ligand Pharmaceuticals (LGND)
As of December 2024, Ligand Pharmaceuticals has a market cap of $2.10B. This makes Ligand Pharmaceuticals the world's 1666th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Ligand Pharmaceuticals from 1992 to 2024
-
Value:-
Market cap history of Ligand Pharmaceuticals from 1992 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $1.28B | 3.12% |
| 2023 | $1.25B | 6.92% |
| 2022 | $1.16B | -30.67% |
| 2021 | $1.68B | 55.31% |
| 2020 | $1.08B | -4.64% |
| 2019 | $1.13B | -23.15% |
| 2018 | $1.48B | -0.90% |
| 2017 | $1.49B | 34.76% |
| 2016 | $1.11B | -6.28% |
| 2015 | $1.18B | 103.76% |
| 2014 | $578.77M | 1.16% |
| 2013 | $572.14M | 153.62% |
| 2012 | $225.59M | 74.73% |
| 2011 | $129.11M | 33.07% |
| 2010 | $97.02M | -31.49% |
| 2009 | $141.62M | -20.80% |
| 2008 | $178.82M | -43.27% |
| 2007 | $315.22M | -55.89% |
| 2006 | $714.63M | -1.79% |
| 2005 | $727.68M | -4.21% |
| 2004 | $759.66M | -20.76% |
| 2003 | $958.71M | 173.56% |
| 2002 | $350.46M | -70.00% |
| 2001 | $1.17B | 27.86% |
| 2000 | $913.68M | 8.74% |
| 1999 | $840.26M | 10.75% |
| 1998 | $758.68M | -9.71% |
| 1997 | $840.26M | -13.45% |
| 1996 | $970.78M | 38.37% |
| 1995 | $701.57M | 30.30% |
| 1994 | $538.42M | -29.79% |
| 1993 | $766.84M | 11.90% |
| 1992 | $685.26M | - |
LGND Market Cap Today is $2.10B -1.56% - 18 Dec 2024
View largest stocks by market cap 
